Ema

What Ema does

Ema (legal entity SocialMama, Inc., dba Ema and Ema EQ) is a Houston-based, privately held B2B health AI company founded in 2019 that sells a clinically grounded conversational and predictive AI platform to health brands, digital health platforms, femtech companies, diagnostics and pharma firms, and enterprise wellness programs. The company's flagship product, Ema, is a proprietary hybrid language model fine-tuned on a 10M+ real-world women's health conversation corpus, layered with biopsychosocial and nursing-model frameworks, an EmaGuard safety and moderation layer (citation grounding, conflict detection, hallucination controls), human-in-the-loop review against ASCO/WHO/HEDIS standards, and agentic tools for navigation, adaptive capabilities, and a curiosity engine. The platform is exposed as a single clinical-inference API with prebuilt UI kits, plug-and-play prompts, and escalation/triage flows, and powers a modular product surface including Ema Concierge (chat/website), Ema Insight (predictive analytics), Ema Analyst (enterprise dashboard), Clinical Module, Hormonal Health & Fertility module, Care Navigation Protocol Engine, and Ops Intelligence.

Ema generates revenue primarily through recurring B2B SaaS and API licensing of its clinical reasoning engine to enterprise and mid-market partners, supplemented by white-glove implementation services (protocol mapping, integration, QA) bundled into annual enterprise contracts priced on a quote basis. Go-to-market is sales-led and enterprise field-sales driven, with CTAs for demo booking rather than self-serve signup; Ema also positions toward API-first developer distribution with a developer portal and SDKs listed as Coming Soon. The company is reported to be in production with 50+ tenants across verticals including maternal health, postpartum, lactation, fertility, mental health, pelvic health, hormone health, femtech, care delivery, enterprise wellness, and digital health, with named partners such as Lovu Health, PatientsLikeMe, Coddle, Flourish Care, Willow, Work&, Aavia, Embr Wave, Free to Feed, Mamaya, and Pelvic People. As of 2025 Ema rebranded under the Ema EQ parent identity to position the underlying Emotion Engine as infrastructure for emotionally intelligent AI across adjacent health verticals, and in Spring 2026 it is co-founding the Women's Health AI (WHAI) Consortium with Willow, Clue, Oura, Carrot Fertility, Thrive Global, and Harvard to set shared benchmarks and governance for AI in women's health.

Name

Ema

Legal name

SocialMama, Inc.

Website

https://emaapp.co

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Ema (SocialMama, Inc.) is a Houston-based B2B health AI company that sells a proprietary hybrid language model, trained on 10M+ women's health conversations, as an API and embedded AI layer to femtech brands, digital health platforms, diagnostics, pharma, and enterprise wellness partners across 50+ production tenants.

Ownership category

akta.pro rank

Product category

Healthcare AI Software

NAICS

Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511)

SIC

Services-Computer Integrated Systems Design (7373), Services-Computer Programming Services (7371)

akta.pro primary industry

EHR Implementation, Optimization, Training & Managed Services (HLACAAAL)

akta.pro secondary industries

EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps (HLACAAAN), Enterprise Integration Engines & Interface Management (HL7 v2/X12/API) (HLACABAC)

Keywords

• Conversational AI healthcare
• Women's health AI platform
• Clinical reasoning API
• Health AI infrastructure
• Embedded health assistant

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

1. B2B Enterprise SaaS / API Licensing: Ema is offered as a B2B intelligence layer and API sold to health companies, digital health platforms, femtech brands, diagnostics and pharma companies, with white-glove implementation. Revenue is generated by licensing the AI platform/API to enterprise partners on a recurring basis (recurring SaaS/usage).
2. White-Glove Implementation & Integration Services: Implementation services including protocol mapping, integration, and QA testing accompany deployment; these professional/managed services are typically bundled into enterprise contracts and contribute to deal size alongside the platform license.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Ema is a B2B emotionally intelligent AI platform for women's health and wellness, sold to health brands, digital health platforms, femtech companies, pharma, diagnostics, and enterprise wellness providers. The hybrid language model is trained on a proprietary 10M+ women's health conversation corpus and deployed via API, embedded UI kits, or chat to deliver clinically grounded conversational triage, education, adherence support, escalation, and predictive insights. Implementation is delivered through white-glove enterprise onboarding that maps protocols, ingests per-tenant clinical content, and validates QA.

Product overview

Ema EQ operates as a platform-plus-modules architecture. The flagship product, Ema, is a hybrid language model Emotion Engine that serves as the core intelligence layer, accessed through three deployment modes: Conversational (chat), Embedded (in-product UI), and Omniscient (always-on background monitoring). The same core powers Ema Concierge (website/chat interface), Ema Insight (predictive analytics), the Hormonal Health & Fertility clinical module, and broader Clinical Module (assessments/red-flag escalation), Care Navigation/Protocol Engine, and Ops Intelligence modules. Enterprise analytics are surfaced through Ema Analyst. Technical integration is enabled through the Ema API, which exposes clinical reasoning, per-tenant knowledge ingestion, and prebuilt escalation flows, with a Developer Portal and SDKs listed as Coming Soon. The WHAI Consortium is Ema EQ's co-founded industry initiative to set governance standards for women's health AI.

Differentiator

Problem solved

Functional benefit

Brands

• Ema: Flagship emotionally intelligent AI product for women's health and wellness, trained on 10M+ real-world care conversations and deployed as an API/intelligence layer across 50+ health brand tenants.

Products and services

• Ema Flagship emotionally intelligent AI health assistant for women's health and wellness. Provides clinically-grounded conversational triage, education, adherence support, and care navigation across women's health and adjacent verticals, deployed via chat, embedded UI, or API to enterprise health partners.
• Ema API Single developer-facing API for clinical reasoning and insights that integrates Ema's hybrid language model into any digital health experience. Supports per-tenant knowledge ingestion (PDFs, clinical guidelines), prebuilt escalation and triage flows, plug-and-play prompts for health-specific use cases, and exposes the Ema Inference engine with clinical guardrails.

Quantifiable outcome

• 36% increase in product & service utilization
• +7 more outcomes

Named customers11 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature8 records

Partnerships

18 partnerships are on record, tiered core, major and flagship.

• Lovu HealthcoreTechnology or IntegrationLovu Health integrated Ema AI into its patient platform to support real-time patient conversations for pregnant patients and new mothers. Ema manages front-line message volume, trained on 10M+ women's health conversations and reviewed by OB clinical advisors. Since the integration, Lovu has recorded zero client complaints about responsiveness. The partnership is between two women-led companies and is presented as a shift toward proactive, real-time care delivery.
• Center for Reproductive RightsmajorStrategic or Co-development PartnerSelect model built in partnership with the Center for Reproductive Rights; logo appears on the Science & Safety page among "Select models built in Partnership With."
• Nurture TherapycoreStrategic or Co-development PartnerSelect model built in partnership with Nurture Therapy; logo appears on the Science & Safety page.
• The Natural NipplecoreStrategic or Co-development PartnerSelect model built in partnership with The Natural Nipple; logo appears on the Science & Safety page.
• I Need an AcoreStrategic or Co-development PartnerSelect model built in partnership with I Need an A; logo appears on the Science & Safety page.
• Stanford UniversitymajorStrategic or Co-development PartnerSelect model built in partnership with Stanford University; logo appears on the Science & Safety page alongside other clinical partners.
• WHAI Consortium (Willow, Ema EQ, Clue, Oura, Carrot Fertility, Thrive Global)flagshipStrategic or Co-development PartnerEma EQ is a founding member of the Women's Health AI (WHAI) Consortium, alongside Willow (Sarah O'Leary, CEO), Clue (Audrey Tsang, former CEO), Oura (Tanvi Jayaraman, MD, Clinical Lead), Carrot Fertility (Asima Ahmad, MD, CMO), Thrive Global, and Harvard (Ethan Cowan, PhD), with Latham & Watkins (Jennifer Yoo) as board observer. The consortium is writing the first shared benchmarks and governance framework for AI in women's health and is inaugurating at Women's Health Week in NYC, Spring 2026.
• Latham & WatkinscoreImplementation/ SI/ Consulting PartnerJennifer Yoo, Partner at Latham & Watkins, sits as a board observer of the WHAI Consortium alongside Ema EQ, Willow, Clue, Oura, Carrot Fertility, Thrive Global, and Harvard. Provides governance and legal oversight for the consortium's framework.
• WillowmajorTechnology or IntegrationWillow appears both as a paying Ema partner under "FemTech" on the Partners page and as a co-founding member of the WHAI Consortium with Ema EQ. Sarah O'Leary, CEO of Willow, sits on the WHAI founding board.
• AaviacoreTechnology or IntegrationAavia is listed as an Ema partner under the "Hormone Health" vertical on the Partners page.
• Embr WavecoreTechnology or IntegrationEmbr Wave is listed as an Ema partner under the "Thermal Wellness" vertical on the Partners page.
• Free to FeedcoreTechnology or IntegrationFree to Feed is listed as an Ema partner under the "Lactation Support" vertical on the Partners page.
• MamayacoreTechnology or IntegrationMamaya is listed as an Ema partner under the "Mental Health" vertical on the Partners page.
• Pelvic PeoplecoreTechnology or IntegrationPelvic People is listed as an Ema partner under the "Pelvic Health" vertical on the Partners page.
• Flourish CarecoreTechnology or IntegrationFlourish Care is listed as an Ema partner under the "Care Delivery" vertical on the Partners page.
• PatientsLikeMecoreTechnology or IntegrationPatientsLikeMe is listed as an Ema partner under the "Digital Health" vertical on the Partners page.
• CoddlecoreTechnology or IntegrationCoddle is listed as an Ema partner under the "Postpartum Care" vertical on the Partners page.
• Work&coreTechnology or IntegrationWork& is listed as an Ema partner under the "Enterprise Wellness" vertical on the Partners page.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Hippocratic AI: Hippocratic AI builds a safety-focused large language model specifically for healthcare, sold via API/enterprise contracts to providers and digital health platforms. It is the closest direct peer to Ema in terms of a vertically specialized clinical LLM delivered through enterprise sales.
• Woebot Health: Woebot Health builds clinically validated conversational AI for mental health, sold to payers, providers, and digital health platforms via enterprise contracts. Comparable to Ema's emotional-intelligence + clinical-guardrails architecture and B2B SaaS/API distribution to health brands.
• Ada Health: Ada Health provides an AI symptom assessment and triage engine embedded into health systems, insurers, and digital health apps via API. Comparable to Ema in clinical reasoning API, triage/escalation flows, and white-label enterprise deployment.
• Carrot Fertility: Carrot Fertility is a fertility, family-forming, and women's health benefits platform that combines human care with AI-driven personalization for employers and payers. Comparable to Ema as a women's-health specialty partner with overlapping customer profile and a co-founder in the WHAI Consortium.
• Clue: Clue operates a leading women's health tracking and insights app with cycle, fertility, and mental health modules. Comparable to Ema as a women's health data and content brand and a co-founding member of the WHAI Consortium, with overlapping end users.

Broad incumbents

• Maven Clinic: Maven Clinic is the largest women's and family health virtual care platform, with proprietary digital health content, care navigation, and AI-enhanced member experiences. It is comparable to Ema as a major women's health platform buyer of (or competitor to) embedded AI clinical reasoning layers.
• Tia: Tia operates women's health primary care clinics with a strong digital front door and care navigation layer. Comparable to Ema as an end-to-end women's health platform that could either buy Ema's embedded AI or compete with it for digital health brand mindshare.
• Sword Health: Sword Health is a digital health platform combining AI-powered care with human clinicians for musculoskeletal and chronic conditions. Comparable to Ema as a digital health platform integrating proprietary AI with clinical safety rails and selling to enterprises.
• K Health: K Health combines an AI symptom checker with virtual primary care, sold to consumers, payers, and enterprises. Comparable to Ema as a vertically integrated AI + clinical workflow product in women's and family health, with API/embedded distribution to partners.
• Babylon Health: Babylon Health built an AI-driven clinical assessment and triage platform deployed via enterprise and government contracts globally. Comparable to Ema in the convergence of conversational AI, clinical reasoning, and population-scale care navigation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/emaapp
• Xx.com/emaappco

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds5 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ema